Floyd E. Bloom, M.D.
Founder; Chairman of the Board
Dr. Bloom is the immediate past Editor-in-Chief
of Science, the world's premier journal of scientific thought
and discovery, and the Chairman of the Department of Neuropharmacology
at The Scripps Research Institute in La Jolla. A member of
the National Academy of Sciences since 1977, he is the recipient
of numerous prizes for his contributions to science, including
the Janssen Award in the Basic Sciences and the Pasarow Award
in Neuropsychiatry. He has also been named a member of the
Royal Swedish Academy of Sciences and a member of the Institute
of Medicine. Dr. Bloom's more than 600 publications include
the seminal work: The Biochemical Basis of Neuropharmacology.
Warren G. Young, Ph.D.
Dr. Young is a former member of the faculty
at the Neuropharmacology Department of The Scripps Research
Institute where he served as the Director of Neuropharmacology
Computing for 17 years. At Scripps, he specialized in the
development of advanced informatics approaches to neurobiology.
A founder of two consulting companies (YBM, Inc. and YTIG,
Inc.) that lead to the development of Neurome, Inc., Dr. Young
is the co-developer of The Brain Browser™
and the NeuroZoom™ technology. In addition
to more than 87 publications, Dr. Young is the immediate past
Managing Editor of Brain Research, developer of the electronic
workflow system for neuroscience journals at Elsevier Science
Publishers known as SmartWorks 2000™,
and served on the National Institute of Mental Health Small
Business Innovation Research and Science and Technology Transfer
scientific review committee.
John H. Morrison, Ph.D.
Dr. Morrison is Professor and Chairman of the Department of Neuroscience at Mount Sinai School of Medicine in New York, where he is also the Johnson Professor of Geriatrics and Adult Development in Neurobiology of Aging. Dr. Morrison has published more than 240 papers, many dealing with the neurobiological events that accompany normal aging and how they differ from the cellular and molecular alterations associated with neurodegenerative disorders such as Alzheimer's Disease, a major focus for Neurome as well. Dr. Morrison has been recognized for his research through several awards and has served on numerous National Institutes of Health Advisory Panels as well as Scientific Advisory Boards for foundations such as the American Federation of Aging Research, Institute for the Study of Aging, Bachmann-Strauss Dystonia and Parkinson Foundation, and the Brookdale Foundation. Along with Drs. Bloom and Young, Dr. Morrison was also a founder of YBM, Inc., the company that led to the formation of Neurome, Inc.
Robert J. Sutcliffe
Mr. Robert J. Sutcliffe is a founding member of Neurome’s board of directors. Mr. Sutcliffe is a venture lawyer and business advisor based in Los Angeles, and is the Managing Director of Craftsman Capital Advisors LLC, specializing in representation of entrepreneurs and venture investors in the technology, biotechnology, hospitality, entertainment and fashion industries. A graduate of UCLA and Harvard Law School, Mr. Sutcliffe was – until 1989 – a Partner and Chairman of the corporate practice group in the Los Angeles office of Brobeck, Phleger & Harrison, where his practice focused on venture capital, corporations and securities. He then served as Congressional Chief of Staff to his law school classmate, the Honorable Christopher Cox of California (former Chairman of the House Policy Committee and the Select Committee on Homeland Security and now Chairman of the Securities and Exchange Commission) and subsequently was a Director, Chief Operating Officer and General Counsel for International Medication Systems Limited, a Southern California-based manufacturer of pharmaceuticals and drug delivery devices. Later, Mr. Sutcliffe served as a director, President and CEO of Digital Gene Technologies, Inc., a genomics-based drug discovery and development company, and he presently serves as Chairman of Miravant Medical Technologies, Inc., a public company developing products in the opthomology and cardiovascular fields based on photodynamic therapy. Mr. Sutcliffe has served on the Board of Trustees of the Yosemite Fund and the Board of Counselors of the UCLA Dental School, and as a Trustee of the Junior Statesmen of America.
Mr. Michael Khoury joined Deloitte & Touche, one of the nation’s leading professional services firms, in 1989 and served as Senior Manager until 1993. From 1993 to 1998 Mr. Khoury served first as President, then CEO of First National Mortgage Exchange. He was Senior Vice President at IMC Mortgage, a consumer finance company, from 1998 to 1999. In 1999 he was appointed CEO of InterScore, a consulting firm that he sold in 2000 to Ballantyne, Inc., a consulting firm focused on Enterprise Resource Planning systems, where he remained as a Senior Vice President until 2003. Mr. Khoury currently serves as a Director on the Boards of Miravant Medical Technologies, Inc. and Senetek PLC. He holds a B.S. in Mathematics from the American University of Beirut, an MFA from New York University, and an MBA from UCLA. He is a Fulbright Scholar and was a CPA (inactive status) from 1993 to 2004.
Joseph H. Wender
Mr. Joseph H. Wender is a Managing Director at GSC Partners, a private investment firm specializing in a broad array of alternative investments. Prior to joining GSC in 2005, he served as Advisory Director and Senior Director of the Financial Institutions Group at Goldman, Sachs & Co. Mr. Wender joined Goldman Sachs in 1971 and became a General Partner of that firm in 1982. He was involved in most large mergers in the banking industry over the 80's and 90's, including the BankAmerica/Nations merger, the Wells Fargo/Norwest merger, and the Chase/Chemical merger. Mr. Wender also sits on the boards of Isis Pharmaceuticals, First Coastal Bancshares and Affinity Financial. He is also involved with a number of not-for-profit institutions, serving as a board member of the St. Helena Hospital, Copia (the American Center for Wine, Food & the Arts), and the Actors Fund. Mr. Wender and his wife, Ann Colgin, produce a line of ultra premium wines in Napa Valley under the Colgin Cellars label. Mr. Wender received his Bachelors degree from Northwestern University, his LLB from Yale Law School, and graduated with Highest Distinction as a Baker Scholar from the Harvard Graduate School of Business Administration.